MreB Perturbing Compound A22 hydrochloride is an inhibitor of MreB, an actin-like bacterial protein, and has been proved to be an antibiotic adjuvant. MreB Perturbing Compound A22 hydrochloride inhibition of MreB disrupts the bacterial actin cytoskeleton, which can cause an increase in cell permeability and altered transport.